Your browser doesn't support javascript.
loading
[Functional investigation of chimeric antigen receptor T cells targeting LMP1 antigen].
He, H Z; Xing, Y Y; Zhang, Y; Xu, Y X; Tian, Z; Xing, H Y; Tang, K J; Rao, Q; Wang, J X; Wang, M.
Affiliation
  • He HZ; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Peking Union Medical University, CAMS & PUMC, Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Tianjin 300020, China.
  • Xing YY; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Peking Union Medical University, CAMS & PUMC, Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Tianjin 300020, China.
  • Zhang Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Peking Union Medical University, CAMS & PUMC, Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Tianjin 300020, China.
  • Xu YX; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Peking Union Medical University, CAMS & PUMC, Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Tianjin 300020, China.
  • Tian Z; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Peking Union Medical University, CAMS & PUMC, Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Tianjin 300020, China.
  • Xing HY; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Peking Union Medical University, CAMS & PUMC, Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Tianjin 300020, China.
  • Tang KJ; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Peking Union Medical University, CAMS & PUMC, Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Tianjin 300020, China.
  • Rao Q; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Peking Union Medical University, CAMS & PUMC, Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Tianjin 300020, China.
  • Wang JX; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Peking Union Medical University, CAMS & PUMC, Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Tianjin 300020, China.
  • Wang M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Peking Union Medical University, CAMS & PUMC, Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Tianjin 300020, China.
Zhonghua Xue Ye Xue Za Zhi ; 43(3): 229-234, 2022 Mar 14.
Article in Zh | MEDLINE | ID: mdl-35405781
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Viral Matrix Proteins / Receptors, Chimeric Antigen / Lymphoma Limits: Humans Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2022 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Viral Matrix Proteins / Receptors, Chimeric Antigen / Lymphoma Limits: Humans Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2022 Document type: Article Affiliation country: China Country of publication: China